Lipids & metabolic liver disease

Reduced circulating Mig-6 levels are associated with dysglycemia in metabolic dysfunction associated steatotic liver disease (MASLD)

BMJ Open Diabetes Res CarePublished Cross-sectional study

Authors' conclusion

Serum Mig-6 levels may identify MASLD patients at an increased risk of dysglycemia and positively correlate with pancreatic β-cell dysfunction.

Study context

Population
MASLD patients with F2 and F3 fibrosis (FIB-4 1.3–2.67, assessed by vibration-controlled transient elastography); glycaemic status per American Diabetes Association criteriaF2–F3 fibrosis
Participants
119 patients
Exposure
Serum Mig-6 in MASLD with normal glucose tolerance (NGT) vs impaired glucose tolerance vs treatment-naïve T2D
  • NGTn = 35reference
  • Impaired glucose tolerancen = 44
  • Treatment-naïve T2Dn = 40
Outcome
Serum Mig-6 level in MASLD with or without dysglycemia and its association with HOMA-β

Main finding

As reported in the abstract

Serum Mig-6 level
Participants with dysglycemia had lower serum Mig-6 levels vs NGT
p<0.05
Mig-6 cut-off <97.49 pg/mL predicting dysglycemia in steatohepatitis: sensitivity
77.50%
Mig-6 cut-off <97.49 pg/mL predicting dysglycemia: specificity
73.08%

Observational data: associations, not effects.

Further findings

OutcomeNGTTreatment-naïve T2D
Low serum Mig-6 (below cut-off)22%74.2%

Metabolic syndrome by FIB-4 (479 MASLD patients)

Metabolic syndrome with FIB-4>1.3
68%
Metabolic syndrome with FIB-4<1.3
27%
Reduced serum Mig-6 level in FIB-4 >1.3

Mig-6 for identifying β-cell dysfunction

PPV
79.41%
NPV
85.17%
PPV, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)>1.6
80%
NPV, HOMA-IR>1.6
86.67%
HOMA-β lower with Mig-6 below cut-off (97.49 pg/mL)

Original publication

Reduced circulating Mig-6 levels are associated with dysglycemia in metabolic dysfunction associated steatotic liver disease (MASLD). BMJ Open Diabetes Res Care. Published 3 June 2026. doi:10.1136/bmjdrc-2026-005947

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.